http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103169924-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c44f590f393448f635036e2e56cf0159
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-413
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b582bacdae2da116a7d48d4d21f90350
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33e0ef2115fc12a7d615ec9c3035c5b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aabf4be281e0f23d620d5d36326e217e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_790f6e920cec3457d149afcb0ec20e9f
publicationDate 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103169924-B
titleOfInvention Traditional Chinese medicine pill for treating acute cholecystitis
abstract The invention relates to the field of medicine formula, and in particular relates to a traditional Chinese medicine pill for treating acute cholecystitis. The traditional Chinese medicine pill is characterized by comprising the following raw materials in parts by weight: 80-100 parts of radix bupleuri, 80-100 parts of radix aucklandiae, 80-100 parts of fructus aurantii, 80-100 parts of radix curcumae, 120-140 parts of herba artemisiae capillaris, 80-100 parts of radix gentiana, 250-280 parts of pig bile, 80-100 parts of fructus gardeniae, 60-80 parts of radix scutellariae, 80-100 parts of radix paeoniae alba, 80-100 parts of fructus citri sarcodactylis and 80-100 parts of rhizoma cyperi; the 12 raw material medicines are mixed, uniformly stirred and dried in the sun and then ground into fine powder; and a proper amount of adhesive is added to the powder to obtain pills. The traditional Chinese medicine pill provided by the invention has a good treatment effect, prevents obvious toxic and side effects, and is suitable for acute cholecystitis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105797076-A
priorityDate 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID107240
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID114476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487501
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID136209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41375
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID107240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456255
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID114476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491969
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID136209

Total number of triples: 29.